Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12

Ana-Alicia Beltran-Bless, Mark J Clemons, Christian Fesl, Richard Greil (Co-Autor/-in), Gregory R Pond, Marija Balic, Lisa Vandermeer, Vesna Bjelic-Radisic, Christian F Singer, Guenther G Steger, Ruth Helfgott, Daniel Egle, Lidija Sölkner, Simon Peter Gampenrieder (Co-Autor/-in), Stephanie Kacerovsky-Strobl, Christoph Suppan, Magdalena Ritter, Gabriel Rinnerthaler (Co-Autor/-in), Georg Pfeiler, Hannes FohlerDominik Hlauschek, John Hilton, Michael Gnant

Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

2 Quellenangaben (Web of Science)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medicine and Dentistry